| Literature DB >> 29393920 |
Hans Orru1,2, Jane Idavain3,4, Mihkel Pindus5, Kati Orru6, Kaisa Kesanurm7, Aavo Lang8, Jelena Tomasova9.
Abstract
Eastern Estonia has large oil shale mines and industrial facilities mainly focused on electricity generation from oil shale and shale oil extraction, which produce high air pollution emissions. The "Study of the health impact of the oil shale sector-SOHOS" was aimed at identifying the impacts on residents' health and annoyance due to the industrial processing. First, a population-wide survey about health effects and annoyance was carried out. Second, the total and oil shale sectors' emitted concentrations of benzene, phenol, and PM2.5 were modelled. Third, the differences between groups were tested and relationships between health effects and environmental pollution studied using multiple regression analysis. Compared to the control groups from non-industrial areas in Tartu or Lääne-Viru, residents of Ida-Viru more frequently (p < 0.05) reported wheezing, chest tightness, shortness of breath, asthma attacks, a long-term cough, hypertension, heart diseases, myocardial infarction, stroke, and diabetes. All health effects except asthma were reported more frequently among non-Estonians. People living in regions with higher levels of PM2.5, had significantly higher odds (p < 0.05) of experiencing chest tightness (OR = 1.13, 95% CI 1.02-1.26), shortness of breath (1.16, 1.03-1.31) or an asthma attack (1.22, 1.04-1.42) during the previous year. People living in regions with higher levels of benzene had higher odds of experiencing myocardial infarction (1.98, 1.11-3.53) and with higher levels of phenol chest tightness (1.44, 1.03-2.00), long-term cough (1.48, 1.06-2.07) and myocardial infarction (2.17, 1.23-3.83). The prevalence of adverse health effects was also higher among those who had been working in the oil shale sector. Next to direct health effects, up to a quarter of the residents of Ida-Viru County were highly annoyed about air pollution. Perceived health risk from air pollution increased the odds of being annoyed. Annoyed people in Ida-Viru had significantly higher odds of experiencing respiratory symptoms during the last 12 months, e.g., wheezing (2.30, 1.31-4.04), chest tightness (2.88, 1.91-4.33 or attack of coughing (1.99, 1.34-2.95).Entities:
Keywords: benzene; cardiovascular; oil shale; particulate matter; phenol; respiratory; shale oil
Mesh:
Substances:
Year: 2018 PMID: 29393920 PMCID: PMC5858321 DOI: 10.3390/ijerph15020252
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Figure 1Oil shale industry facilities, air quality monitoring stations and annual average concentrations (μg/m3) of fine particles (PM2.5), benzene, and phenol in the ambient air of Ida-Viru County.
Socio-demographic characteristics of the respondents, n (%).
| Ida-Viru County | Lääne-Viru County | Tartu | Total | |
|---|---|---|---|---|
| Female | 508 (59.8) | 105 (57.7) | 1430 (60) | 2046 (59.9) |
| 18–27 | 78 (9.2) | 20 (11) | 277 (11.6) | 376 (11) |
| 28–37 | 105 (12.4) | 28 (15.5) | 462 (19.4) | 598 (17.5) |
| 38–47 | 171 (20.2) | 34 (18.7) | 949 (39.8) | 1151 (33.7) |
| 48–57 | 204 (24) | 48 (26.6) | 467 (19.6) | 717 (21) |
| 58–67 | 241 (28.4) | 38 (21) | 224 (9.4) | 505 (14.8) |
| 68+ | 49 (5.8) | 13 (7.2) | 5 (0.2) | 68 (2) |
| Underweight (BMI < 20) | 62 (7.3) | 10 (5.6) | 231 (9.7) | 304 (8.9) |
| Healthy (BMI 20–24.99 | 254 (29.9) | 61 (33.7) | 1020 (42.8) | 1339 (39.2) |
| Overweight (BMI 25–30) | 306 (36) | 64 (34.9) | 713 (29.9) | 1079 (31.6) |
| Obese (BMI > 30) | 228 (26.8) | 47 (25.8) | 420 (17.6) | 693 (20.3) |
| Estonian | 272 (32) | 153 (84) | 2026 (85) | 2179 (63.8) |
| Russian | 517 (60.9) | 21 (11.6) | 312 (13.1) | 1093 (32) |
| Other | 60 (7.1) | 8 (4.4) | 45 (1.9) | 143 (4.2) |
| Under 100 € | 39 (4.6) | 2 (1.2) | 43 (1.8) | 99 (2.9) |
| 100–299 € | 246 (29) | 33 (18.1) | 322 (13.5) | 686 (20.1) |
| 300–499 € | 301 (35.4) | 67 (36.7) | 665 (27.9) | 1079 (31.6) |
| 500–799 € | 161 (19) | 52 (28.8) | 701 (29.4) | 861 (25.2) |
| 800–999 € | 55 (6.5) | 8 (4.5) | 336 (14.1) | 348 (10.2) |
| Over 1000 € | 47 (5.5) | 19 (10.7) | 317 (13.3) | 342 (10) |
| Elementary or basic | 79 (9.3) | 21 (11.6) | 122 (5.1) | 222 (6.5) |
| Secondary | 540 (63.6) | 121 (66.3) | 1082 (45.4) | 1745 (51.1) |
| Applied or higher | 230 (27.1) | 40 (22.1) | 1180 (49.5) | 1448 (42.4) |
| Have been working | 239 (28.2) | 1 (0.5) | 48 (2) | 287 (8.4) |
| Current smoker | 212 (25) | 39 (21.3) | 460 (19.3) | 710 (20.8) |
| Ex-smoker | 179 (21.1) | 37 (20.2) | 434 (18.2) | 649 (19) |
| Very good | 30 (3.5) | 11 (6.1) | 384 (16.1) | 345 (10.1) |
| Good | 241 (28.4) | 71 (39.2) | 1321 (55.4) | 1468 (43) |
| Average | 456 (53.7) | 78 (43.1) | 594 (24.9) | 1305 (38.2) |
| Bad | 112 (13.2) | 20 (11) | 79 (3.3) | 273 (8) |
| Very bad | 11 (1.3) | 1 (0.6) | 10 (0.4) | 27 (0.8) |
| Single | 113 (13.3) | 38 (20.8) | 432 (18.1) | 584 (17.1) |
| Married | 464 (54.7) | 84 (46.1) | 1087 (45.6) | 1636 (47.9) |
| Cohabiting | 122 (14.4) | 37 (20.2) | 620 (26) | 779 (22.8) |
| Divorced | 94 (11.1) | 16 (9) | 210 (8.8) | 321 (9.4) |
| Widowed | 55 (6.5) | 7 (4) | 33 (1.4) | 99 (2.9) |
The prevalence of respiratory and cardiovascular diseases in different counties and among ethnic groups, n (%).
| Ida-Viru County | Lääne-Viru County | Tartu | Estonians | Non-Estonians | |
|---|---|---|---|---|---|
| Wheezing without a cold | 66 (36.2) | 427 (17.9) | 405 (30.0) | ||
| Chest tightness | 42 (23.3) | 403 (16.9) | 215 (15.9) | ||
| Shortness of breath | 27 (14.6) | 286 (12.0) | 143 (10.6) | ||
| Attack of coughing | 77 (42.2) | 997 (41.8) | 539 (39.9) | 324 (42.3) | |
| Asthma attack | 12 (6.7) | 91 (3.8) | 62 (4.6) | ||
| Wheezing | 37 (20.5) | 539 (22.6) | 251 (18.6) | ||
| Long-term cough | 41 (22.3) | 498 (20.9) | 259 (19.2) | ||
| Nose allergies/hay fever | 185 (21.8) | 41 (22.5) | 577 (24.2) | 320 (23.7) | 157 (20.5) |
| Asthma | 64 (7.5) | 15 (8.0) | 174 (7.3) | 91 (6.7) | 58 (7.5) |
| COPD | 20 (2.4) | 3 (1.7) | 24 (1.0) | 12 (0.9) | |
| Hypertension | 59 (32.2) | 370 (15.5) | 181 (13.4) | ||
| Heart disease | 18 (10.0) | 241 (10.1) | 85 (6.3) | ||
| Myocardial infarction | 7 (4.1) | 48 (2.0) | 16 (1.2) | ||
| Stroke | 4 (2.4) | 24 (1.0) | 11 (0.8) | ||
| Diabetes | 11 (5.8) | 69 (2.9) | 35 (2.6) | ||
1 Respondents from Ida-Viru County different (p < 0.05) from respondents from Tartu; 2 Respondents from Ida-Viru County different (p < 0.05) from respondents from Lääne-Viru County; 3 Non-Estonian respondents different (p < 0.05) from Estonian respondents; Values in bold: p < 0.05.
Odds ratios (95% CI) on disease prevalence per interquartile change in pollutants concentrations.
| PM2.5 | Benzene | Phenol | |
|---|---|---|---|
| Wheezing without a cold | 1.03 (0.92–1.14) | 1.06 (0.79–1.43) | 1.36 (0.98–1.90) |
| Chest tightness | 1.30 (0.96–1.76) | ||
| Shortness of breath | 1.14 (0.80–1.62) | 1.18 (0.80–1.74) | |
| Attack of coughing | 1.04 (0.94–1.15) | 0.94 (0.71–1.24) | 0.95 (0.70–1.30) |
| Asthma attack | 1.14 (0.67–1.95) | 0.60 (0.32–1.15) | |
| Wheezing | 1.10 (0.99–1.22) | 1.16 (0.86–1.56) | 1.11 (0.80–1.55) |
| Long-term cough | 0.99 (0.89–1.11) | 1.31 (0.96–1.77) | |
| Allergic rhinitis | 1.07 (0.94–1.22) | 0.92 (0.64–1.32) | 0.89 (0.59–1.34) |
| Asthma | 1.04 (0.87–1.24) | 1.20 (0.70–2.06) | 0.84 (0.45–1.56) |
| COPD | 1.22 (0.84–1.76) | 1.97 (0.72–2.10) | 1.92 (0.71–5.19) |
| Hypertension | 1.10 (0.98–1.24) | 1.15 (0.83–1.59) | 1.21 (0.84–1.74) |
| Heart disease | 1.12 (0.98–1.28) | 1.24 (0.83–1.84) | 1.30 (0.85–1.98) |
| Myocardial infarction | 0.99 (0.80–1.22) | ||
| Stroke | 1.01 (0.76–1.35) | 1.39 (0.62–3.11) | 1.14 (0.50–2.62) |
| Diabetes | 1.01 (0.85–1.21) | 1.42 (0.86–2.34) | 1.33 (0.78–2.27) |
* Logistic regression analysis was adjusted for gender, age, body mass index (BMI), education, environmental tobacco smoke, smoking history, and income during past 12 months; COPD: Chronic obstructive pulmonary disease; Values in bold: p < 0.05.
Association between specific factors, air pollutants and the prevalence of annoyance in the three investigated counties, odds ratios (95% CI).
| Gender | 1.01 (0.36–2.88) | ||
| Age | 1.00 (0.99–1.02) | 0.99 (0.95–1.03) | 0.99 (0.97–1.02) |
| Elementary or basic education | 1.13 (0.56–2.27) | 0.36 (0.03–4.58) | 1.41 (0.59–3.33) |
| Secondary education | 0.87 (0.56–1.34) | 0.66 (0.21–2.04) | 1.21 (0.78–1.87) |
| Income | 1.08 (0.91–1.27) | 1.17 (0.74–1.85) | 0.89 (0.75–1.05) |
| Current or ex-smokers | 0.89 (0.70–1.13) | 0.50 (0.24–1.05) | 1.04 (0.82–1.35) |
| Self-assessed health status | |||
| PM2.5 | 1.07 (0.94–1.22) | ||
| Benzene | 1.04 (0.87–1.24) | ||
| Phenol | 1.22 (0.84–1.76) | ||
| Working in oil shale sector | 1.36 (0.86–2.15) | 0 | |
| Ethnicity | 1.19 (0.85–1.67) | 0.87 (0.31–2.44) | |
| Perceived risk | |||
| Wheezing without a cold | 0.11 (0.01–0.92) | 0 | |
| Chest tightness | |||
| Shortness of breath | 1.60 (0.92–2.79) | 94.83 (3.35–2680.68) | |
| Attack of coughing | 2.10 (0.75–5.84) | ||
| Asthma attack | 1.48 (0.79–2.77) | 4.83 (0.79–29.35) | 2.16 (0.98–4.75) |
| Wheezing | 1.52 (0.48–4.82) | ||
| Long-term cough | 1.29 (0.86–1.94) | 3.04 (1.01–9.16) * | |
| Allergic rhinitis | 1.40 (0.82–2.37) | 1.36 (0.34–5.45) | 1.34 (0.78–2.27) |
| Asthma | 1.18 (0.60–2.32) | 2.85 (0.6–13.61) | 1.36 (0.65–2.85) |
| COPD | 1.69 (0.56–5.14) | 6.21 (0.16–246.71) | 3.18 (0.78–12.8) |
| Hypertension | 1.05 (0.68–1.63) | 1.13 (0.35–3.69) | 1.12 (0.51–2.47) |
| Heart disease | 1.22 (0.61–2.42) | 7.81 (1.41–43.16) | 0.47 (0.16–1.39) |
| Myocardial infarction | 1.22 (0.61–2.42) | 17.32 (1.47–203.29) | 0 |
| Stroke | 0.69 (0.21–2.24) | 0 | 0 |
| Diabetes | 0.67 (0.35–1.29) | 0.47 (0.04–4.84) | 0.83 (0.09–6.96) |
* Logistic regression analysis was adjusted for gender, age, BMI, education, environmental tobacco smoke, smoking history, and income during past 12 months; # annoyance prevalence per interquartile change in pollutants concentrations; Values in bold: p < 0.05.
Odds ratios (95% CI) on disease prevalence per interquartile change in pollutants concentrations.
| Wheezing without a cold | 1.03 (0.94–1.13) | 1.06 (0.98–1.38) | 1.28 (0.95–1.71) |
| Chest tightness | 1.28 (0.97–1.67) | ||
| Shortness of breath | 1.09 (0.98–1.22) | 1.26 (0.92–1.73) | 1.21 (0.86–1.70) |
| Attack of coughing | 1.03 (0.94–1.13) | 0.90 (0.84–1.15) | 0.89 (0.68–1.17) |
| Asthma attack | 1.20 (1.04–1.38) | 1.24 (0.93–2.00) | 0.64 (0.36–1.12) |
| Wheezing | 1.07 (0.98–1.18) | 1.22 (0.91–1.64) | |
| Long-term cough | 1.00 (0.91–1.11) | ||
| Allergic rhinitis | 1.03 (0.92–1.16) | 0.89 (0.64–1.23) | 0.86 (0.59–1.26) |
| Asthma | 1.11 (0.96–1.30) | 1.39 (0.85–2.26) | 0.80 (0.46–1.39) |
| COPD | 1.09 (0.84–1.41) | 1.59 (0.69–1.77) | 2.07 (0.90–4.76) |
| Hypertension | 1.03 (0.94–1.13) | 1.16 (0.89–1.51) | 1.21 (0.90–1.62) |
| Heart disease | 1.07 (0.95–1.20) | ||
| Myocardial infarction | 0.95 (0.79–1.14) | ||
| Stroke | 0.95 (0.73–1.24) | 1.32 (0.65–2.67) | 1.34 (0.65–2.78) |
| Diabetes | 0.97 (0.83–1.13) | 1.42 (0.92–2.19) | 1.33 (0.85–2.10) |
| Wheezing without a cold | 0.96 (0.76–1.21) | 0.96 (0.56–1.64) | 0.97 (0.83–1.21) |
| Chest tightness | 1.17 (0.93–1.46) | 1.27 (0.72–2.23) | 1.07 (0.92–1.23) |
| Shortness of breath | 1.23 (0.95–1.59) | 1.12 (0.95–1.31) | |
| Attack of coughing | 1.08 (0.88–1.33) | 0.96 (0.59–1.56) | 0.96 (0.84–1.09) |
| Asthma attack | 1.25 (0.89–1.77) | 1.12 (0.68–1.68) | 0.99 (0.71–1.37) |
| Wheezing | 1.05 (0.84–1.32) | 1.17 (0.67–2.04) | 0.96 (0.83–1.12) |
| Long-term cough | 1.24 (0.98–1.58) | 1.09 (0.61–1.96) | 1.01 (0.86–1.18) |
| Allergic rhinitis | 1.00 (0.76–1.32) | 0.63 (0.62–1.19) | 0.76 (0.59–0.97) |
| Asthma | 0.78 (0.48–1.27) | 0.93 (0.66–2.52) | 1.03 (0.81–1.31) |
| COPD | - | - | 0.40 (0.05–3.36) |
| Hypertension | 1.14 (0.89–1.47) | 1.49 (0.79–2.83) | |
| Heart disease | 0.96 (0.65–1.42) | 0.93 (0.67–2.25) | 1.06 (0.85–1.31) |
| Myocardial infarction | 0.96 (0.48–1.92) | 1.38 (0.67–2.19) | 1.23 (0.88–1.72) |
| Stroke | 0.83 (0.09–7.58) | 0.55 (0.13–2.06) | 0.91 (0.48–1.72) |
| Diabetes | 0.83 (0.49–1.40) | 1.21 (0.70–1.90) | 0.95 (0.67–1.34) |
| Wheezing without a cold | 1.04 (0.91–1.18) | 1.03 (0.77–1.38) | |
| Chest tightness | 1.09 (0.96–1.25) | 1.11 (0.82–1.49) | 1.35 (0.91–2.01) |
| Shortness of breath | 1.13 (0.98–1.31) | 0.81 (0.58–1.13) | 0.96 (0.61–1.52) |
| Attack of coughing | 1.05 (0.93–1.19) | 1.02 (0.77–1.36) | 1.05 (0.72–1.53) |
| Asthma attack | 0.99 (0.61–1.61) | ||
| Wheezing | 1.11 (0.97–1.26) | 1.02 (0.77–1.36) | 1.08 (0.73–1.59) |
| Long-term cough | 0.92 (0.80–1.05) | 1.14 (0.85–1.53) | 1.41 (0.96–2.08) |
| Allergic rhinitis | 1.12 (0.95–1.31) | 1.15 (0.80–1.66) | 1.15 (0.71–1.88) |
| Asthma | 1.10 (0.90–1.35) | 1.11 (0.65–1.86) | 0.66 (0.32–1.37) |
| COPD | 1.15 (0.77–1.72) | 1.26 (0.54–2.92) | 1.82 (0.59–5.59) |
| Hypertension | 1.09 (0.95–1.26) | 0.93 (0.68–1.28) | 0.92 (0.60–1.42) |
| Heart disease | 1.15 (0.98–1.35) | 1.01 (0.70–1.47) | 1.02 (0.62–1.67) |
| Myocardial infarction | 0.96 (0.76–1.22) | 1.49 (0.88–2.50) | 1.74 (0.92–3.29) |
| Stroke | 0.99 (0.72–1.35) | 1.11 (0.57–2.16) | 0.85 (0.35–2.09) |
| Diabetes | 1.04 (0.84–1.27) | 1.26 (0.79–2.03) | 1.22 (0.66–2.24) |
| Wheezing without a cold | 1.03 (0.63–1.69) | 1.08 (0.75–1.57) | |
| Chest tightness | 1.10 (0.87–1.40) | 1.47 (0.88–2.44) | 1.37 (0.95–1.97) |
| Shortness of breath | 1.24 (0.96–1.61) | 0.89 (0.49–1.59) | 1.15 (0.75–1.76) |
| Attack of coughing | 1.02 (0.82–1.28) | 1.08 (0.67–1.72) | 0.98 (0.69–1.38) |
| Asthma attack | 2.52 (0.83–7.63) | 0.61 (0.26–1.45) | |
| Wheezing | 1.06 (0.65–1.73) | 0.87 (0.60–1.27) | |
| Long-term cough | 0.99 (0.77–1.28) | 1.30 (0.77–2.19) | 1.41 (0.97–2.07) |
| Allergic rhinitis | 1.27 (0.88–1.82) | 0.99 (0.49–2.02) | 0.86 (0.49–1.51) |
| Asthma | 0.84 (0.55–1.27) | ||
| COPD | 0.55 (0.04–7.84) | 2.16 (0.26–17.91) | 1.33 (0.37–4.70) |
| Hypertension | 1.27 (0.97–1.67) | 1.00 (0.58–1.72) | 0.89 (0.59–1.32) |
| Heart disease | 1.11 (0.82–1.50) | 1.26 (0.68–2.36) | 1.30 (0.84–2.02) |
| Myocardial infarction | 0.71 (0.38–1.32) | 2.26 (0.95–5.37) | 1.60 (0.91–2.81) |
| Stroke | 0.51 (0.20–1.27) | 0.74 (0.26–2.12) | 1.39 (0.72–2.67) |
| Diabetes | 1.20 (0.86–1.68) | 1.58 (0.72–3.48) | 0.95 (0.65–1.38) |
| Wheezing without a cold | 0.97 (0.84–1.12) | 0.99 (0.68–1.44) | 1.24 (0.82–1.87) |
| Chest tightness | 1.30 (0.88–1.91) | 1.30 (0.86–1.96) | |
| Shortness of breath | 1.15 (0.98–1.35) | 1.26 (0.80–1.99) | 1.11 (0.68–1.81) |
| Attack of coughing | 1.03 (0.90–1.18) | 0.91 (0.64–1.28) | 0.91 (0.62–1.34) |
| Asthma attack | 1.07 (0.86–1.34) | 0.76 (0.41–1.41) | 0.58 (0.27–1.25) |
| Wheezing | 1.04 (0.90–1.19) | 1.13 (0.78–1.64) | 1.14 (0.76–1.72) |
| Long-term cough | 0.98 (0.85–1.13) | 1.34 (0.92–1.95) | 1.33 (0.89–2.00) |
| Allergic rhinitis | 1.05 (0.90–1.24) | 0.80 (0.52–1.24) | 0.74 (0.45–1.21) |
| Asthma | 0.91 (0.69–1.18) | 0.81 (0.42–1.55) | 0.72 (0.33–1.57) |
| COPD | 1.30 (0.88–1.92) | 1.98 (0.62–6.31) | 1.87 (0.62–5.64) |
| Hypertension | 1.04 (0.89–1.21) | 1.16 (0.77–1.74) | 1.34 (0.86–2.10) |
| Heart disease | 1.25 (0.92–1.35) | 1.24 (0.73–2.11) | 1.23 (0.70–2.16) |
| Myocardial infarction | 1.08 (0.82–1.43) | 2.07 (0.93–1.06) | |
| Stroke | 1.08 (0.69–1.69) | 3.85 (0.85–17.49) | 1.85 (0.54–6.28) |
| Diabetes | 0.88 (0.65–1.19) | 1.25 (0.66–2.40) | 0.91 (0.45–1.84) |
* Logistic regression analysis was adjusted for gender, age, BMI, education, environmental tobacco smoke, smoking history, and income during past 12 months; Values in bold: p < 0.05.
High annoyance (%) due to air pollution * per demographics and health problems of people in Ida-Viru County and the control regions (Lääne-Viru and Tartu), and regional comparisons.
| Ida-Viru County | Lääne-Viru County | Tartu | Chi2 | ||
|---|---|---|---|---|---|
| 22.4 | 14.9 | 11.8 | 36.70 | ||
| Male | 22.4 | 14.9 | 11.8 | 36.70 | |
| Female | 25.5 | 15.6 | 13.2 | 28.25 | |
| 18–27 | 19.5 | 20.0 | 13.3 | 2.24 | 0.327 |
| 28–37 | 24.5 | 11.1 | 11.0 | 12.68 | |
| 38–47 | 18.4 | 9.1 | 10.1 | 7.15 | |
| 48–57 | 24.5 | 15.6 | 46.2 | 5.28 | 0.071 |
| 58–67 | 24.3 | 20.0 | 22.2 | 0.31 | 0.855 |
| 68+ | 17.5 | 14.3 | 0 | 0.65 | 0.721 |
| Estonian | 18.5 | 13.7 | 10.0 | 13.70 | |
| Non-Estonian | 24.2 | 17.9 | 21.9 | 0.85 | 0.655 |
| Under 100 € | 26.5 | 50.0 | 21.1 | 0.85 | 0.655 |
| 100–299 € | 22.3 | 10.3 | 15.4 | 4.08 | 0.130 |
| 300–499 € | 22.8 | 15.3 | 15.0 | 5.93 | 0.052 |
| 500–799 € | 15.2 | 12.5 | 9.0 | 3.95 | 0.139 |
| 800–999 € | 28.8 | 25.0 | 9.5 | 11.92 | |
| Over 1000 € | 28.6 | 16.7 | 8.2 | 11.62 | |
| Elementary or basic | 25.4 | 13.3 | 16.7 | 2.00 | 0.369 |
| Secondary | 20.9 | 14.2 | 13.1 | 10.70 | |
| Applied or higher | 24.2 | 17.9 | 10.3 | 24.59 | |
| Very good | 14.3 | 23.1 | 6.1 | 6.17 | |
| Good | 17.3 | 7.2 | 10.1 | 9.70 | |
| Average | 21.5 | 16.2 | 17.2 | 1.74 | 0.420 |
| Bad | 37.9 | 10.9 | 27.0 | 1.37 | 0.504 |
| Very bad | 20.0 | 0 | 0 | 35.50 | 0.000 |
| Chest tightness | 36.6 | 27.0 | 22.9 | 8.46 | |
| Shortage of breath | 38.4 | 34.8 | 28.8 | 2.49 | 0.288 |
| Asthma attack | 33.3 | 40.0 | 21.4 | 2.27 | 0.321 |
| Ever had | |||||
| Wheezing | 34.0 | 22.9 | 21.7 | 7.80 | |
| Long-term cough | 28.9 | 25.0 | 19.8 | 4.82 | 0.090 |
| Allergic rhinitis | 25.8 | 18.8) | 15.3 | 6.54 | |
| Asthma | 31.7 | 36.4 | 12.3 | 8.02 | |
| COPD | 30.0 | 33.3 | 30.0 | 0.01 | 0.993 |
* Respondents who rated 7–10 on a 10-point scale, ranging from no annoyance (1) to very high annoyance (10).